Literature DB >> 15177040

AHNAK interacts with the DNA ligase IV-XRCC4 complex and stimulates DNA ligase IV-mediated double-stranded ligation.

Thomas Stiff1, Emma Shtivelman, Penny Jeggo, Boris Kysela.   

Abstract

AHNAK is a high molecular weight protein that is under-expressed in several radiosensitive neuroblastoma cell lines. Using immunoaffinity purification or purified proteins, we show that AHNAK interacts specifically with the DNA ligase IV-XRCC4 complex, a complex that functions in DNA non-homologous end-joining. Furthermore, AHNAK and the DNA ligase IV-XRCC4 complex co-immunoprecipitate demonstrating an in vivo interaction. This interaction is specific and is not observed with other DNA ligases nor with other components of the DNA non-homologous end-joining machinery. We characterised AHNAK as a protein that stimulates the double-stranded (DS) ligation activity of DNA ligase IV-XRCC4. We show that AHNAK has weak DNA-binding activity and forms a stable complex with the DNA ligase IV-XRCC4 complex on DNA. AHNAK is also able to link two DNA molecules to a similar extent to that previously reported for Ku. Together, these findings demonstrate new activities for AHNAK, and raise the possibility that it may function to modulate DNA non-homologous end-joining. Copyright 2003 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177040     DOI: 10.1016/j.dnarep.2003.11.001

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  4 in total

1.  A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation.

Authors:  Didi Matza; Abdallah Badou; Koichi S Kobayashi; Karen Goldsmith-Pestana; Yutaka Masuda; Akihiko Komuro; Diane McMahon-Pratt; Vincent T Marchesi; Richard A Flavell
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

2.  Effects on human transcriptome of mutated BRCA1 BRCT domain: a microarray study.

Authors:  Caterina Iofrida; Erika Melissari; Veronica Mariotti; Chiara Guglielmi; Lucia Guidugli; Maria Adelaide Caligo; Silvia Pellegrini
Journal:  BMC Cancer       Date:  2012-05-30       Impact factor: 4.430

3.  XLF-Cernunnos promotes DNA ligase IV-XRCC4 re-adenylation following ligation.

Authors:  Enriqueta Riballo; Lisa Woodbine; Thomas Stiff; Sarah A Walker; Aaron A Goodarzi; Penny A Jeggo
Journal:  Nucleic Acids Res       Date:  2008-12-04       Impact factor: 16.971

Review 4.  More than Meets the ISG15: Emerging Roles in the DNA Damage Response and Beyond.

Authors:  Zac Sandy; Isabelle Cristine da Costa; Christine K Schmidt
Journal:  Biomolecules       Date:  2020-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.